These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22710312)

  • 21. Age-associated cross-reactive antibody-dependent cellular cytotoxicity toward 2009 pandemic influenza A virus subtype H1N1.
    Jegaskanda S; Laurie KL; Amarasena TH; Winnall WR; Kramski M; De Rose R; Barr IG; Brooks AG; Reading PC; Kent SJ
    J Infect Dis; 2013 Oct; 208(7):1051-61. PubMed ID: 23812238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroconversion to pandemic (H1N1) 2009 virus and cross-reactive immunity to other swine influenza viruses.
    Perera RA; Riley S; Ma SK; Zhu HC; Guan Y; Peiris JS
    Emerg Infect Dis; 2011 Oct; 17(10):1897-9. PubMed ID: 22000365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13.
    Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A
    Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.
    Marcelin G; DuBois R; Rubrum A; Russell CJ; McElhaney JE; Webby RJ
    PLoS One; 2011; 6(10):e26335. PubMed ID: 22039464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic patterns of circulating seasonal and pandemic A(H1N1)pdm09 influenza viruses from 2007-2010 in and around Delhi, India.
    Broor S; Krishnan A; Roy DS; Dhakad S; Kaushik S; Mir MA; Singh Y; Moen A; Chadha M; Mishra AC; Lal RB
    PLoS One; 2012; 7(1):e29129. PubMed ID: 22235265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemagglutination Inhibition Antibody Response Following Influenza A(H1N1)pdm09 Virus Natural Infection: A Cross-Sectional Study from Thirthahalli, Karnataka, India.
    Alladi CSH; Jagadesh A; Prabhu SG; Arunkumar G
    Viral Immunol; 2019 Jun; 32(5):230-233. PubMed ID: 31070522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period.
    Yang SQ; Qu JX; Wang C; Yu XM; Liu YM; Cao B
    Clin Respir J; 2014 Apr; 8(2):185-91. PubMed ID: 24106842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic status for pandemic (H1N1) 2009 virus, Taiwan.
    Huang DT; Shao PL; Huang KC; Lu CY; Wang JR; Shih SR; Chi H; Lai MR; Lee CY; Chang LY; Huang LM
    Emerg Infect Dis; 2011 Jan; 17(1):76-8. PubMed ID: 21192858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
    Bateman AC; Kieke BA; Irving SA; Meece JK; Shay DK; Belongia EA
    J Infect Dis; 2013 Apr; 207(8):1262-9. PubMed ID: 23341536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15.
    Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A;
    Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Age-specific differences in the dynamics of protective immunity to influenza.
    Ranjeva S; Subramanian R; Fang VJ; Leung GM; Ip DKM; Perera RAPM; Peiris JSM; Cowling BJ; Cobey S
    Nat Commun; 2019 Apr; 10(1):1660. PubMed ID: 30971703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serological responses following influenza A H1N1 2009 infection in adults.
    Tan S; Gordon DL; Honda-Okubo Y; Petrovsky N; Phillips P; Huddleston S; Sadlon TA
    J Infect; 2011 May; 62(5):388-93. PubMed ID: 21420426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
    Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
    J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Seroprevalence of influenza A(H1N1)pdm09 virus antibody, England, 2010 and 2011.
    Hoschler K; Thompson C; Andrews N; Galiano M; Pebody R; Ellis J; Stanford E; Baguelin M; Miller E; Zambon M
    Emerg Infect Dis; 2012 Nov; 18(11):1894-7. PubMed ID: 23092684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of the kinetics of granulocytes and lymphocytes between influenza A/H1N1/pdm09 and seasonal influenza A].
    Hirotsu N; Hasegawa T; Saisho Y; Murate J; Ikematsu H; Iwaki N; Kawai N; Kashiwagi S
    Kansenshogaku Zasshi; 2014 Jan; 88(1):117-25. PubMed ID: 24665588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longevity and determinants of protective humoral immunity after pandemic influenza infection.
    Sridhar S; Begom S; Hoschler K; Bermingham A; Adamson W; Carman W; Riley S; Lalvani A
    Am J Respir Crit Care Med; 2015 Feb; 191(3):325-32. PubMed ID: 25506631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
    Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of population susceptibility to upcoming seasonal influenza epidemic strain using interepidemic emerging influenza virus strains.
    Chen LL; Wu WL; Chan WM; Fong CHY; Ng ACK; Ip JD; Lu L; Dissanayake TK; Ding X; Cai JP; Zhang AJX; Tam S; Hung IFN; Chan KH; Yuen KY; To KKW
    Epidemiol Infect; 2019 Sep; 147():e279. PubMed ID: 31556360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of influenza in the post-pandemic phase: Clinical features in hospitalized patients with influenza A (H1N1) pdm09 and H3N2 viruses, during 2013 in Santa Fe, Argentina.
    Kusznierz G; Carolina C; Manuel RJ; Sergio L; Lucila O; Julio B; Mirta V; Pedro M; Graciana M; Andrea U; Elsa Z
    J Med Virol; 2017 Jul; 89(7):1186-1191. PubMed ID: 28004402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced antibody responses to the pandemic (H1N1) 2009 vaccine after recent seasonal influenza vaccination.
    Choi YS; Baek YH; Kang W; Nam SJ; Lee J; You S; Chang DY; Youn JC; Choi YK; Shin EC
    Clin Vaccine Immunol; 2011 Sep; 18(9):1519-23. PubMed ID: 21813667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.